These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 18691098)

  • 1. Immunosuppression in sepsis.
    Lyn-Kew K; Standiford TJ
    Curr Pharm Des; 2008; 14(19):1870-81. PubMed ID: 18691098
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sepsis-induced immunosuppression: from bad to worse.
    Reddy RC; Chen GH; Tekchandani PK; Standiford TJ
    Immunol Res; 2001; 24(3):273-87. PubMed ID: 11817325
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Current trends in inflammatory and immunomodulatory mediators in sepsis.
    Aziz M; Jacob A; Yang WL; Matsuda A; Wang P
    J Leukoc Biol; 2013 Mar; 93(3):329-42. PubMed ID: 23136259
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is boosting the immune system in sepsis appropriate?
    Cavaillon JM; Eisen D; Annane D
    Crit Care; 2014 Mar; 18(2):216. PubMed ID: 24886820
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Host response biomarkers in the diagnosis of sepsis: a general overview.
    Parlato M; Cavaillon JM
    Methods Mol Biol; 2015; 1237():149-211. PubMed ID: 25319788
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Surgical sepsis: dysregulation of immune function and therapeutic implications.
    Boontham P; Chandran P; Rowlands B; Eremin O
    Surgeon; 2003 Aug; 1(4):187-206. PubMed ID: 15570763
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Determining the degree of immunodysregulation in sepsis.
    Cavaillon JM; Adib-Conquy M
    Contrib Nephrol; 2007; 156():101-11. PubMed ID: 17464119
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting high mobility group box 1 as a late-acting mediator of inflammation.
    Czura CJ; Tracey KJ
    Crit Care Med; 2003 Jan; 31(1 Suppl):S46-50. PubMed ID: 12544976
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The immune system's role in sepsis progression, resolution, and long-term outcome.
    Delano MJ; Ward PA
    Immunol Rev; 2016 Nov; 274(1):330-353. PubMed ID: 27782333
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Advances in the understanding and treatment of sepsis-induced immunosuppression.
    Venet F; Monneret G
    Nat Rev Nephrol; 2018 Feb; 14(2):121-137. PubMed ID: 29225343
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of cellular events in the pathophysiology of sepsis.
    Bhan C; Dipankar P; Chakraborty P; Sarangi PP
    Inflamm Res; 2016 Nov; 65(11):853-868. PubMed ID: 27392441
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Host innate immune responses to microbial pathogens.
    Delaloye J; Calandra T
    Curr Vasc Pharmacol; 2013 Mar; 11(2):123-32. PubMed ID: 23506491
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The leptin system: a potential target for sepsis induced immune suppression.
    Tschöp J; Dattilo JR; Prakash PS; Kasten KR; Tschöp MH; Caldwell CC
    Endocr Metab Immune Disord Drug Targets; 2010 Dec; 10(4):336-47. PubMed ID: 20923403
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular basics of sepsis developement.
    Jedynak M; Siemiątkowski A; Rygasiewicz K
    Anaesthesiol Intensive Ther; 2012; 44(4):221-5. PubMed ID: 23348491
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytokine storm and sepsis disease pathogenesis.
    Chousterman BG; Swirski FK; Weber GF
    Semin Immunopathol; 2017 Jul; 39(5):517-528. PubMed ID: 28555385
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Immune System Regulation in Sepsis: From Innate to Adaptive.
    Qiu Y; Tu GW; Ju MJ; Yang C; Luo Z
    Curr Protein Pept Sci; 2019; 20(8):799-816. PubMed ID: 30843486
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Balancing Innate Immunity and Inflammatory State via Modulation of Neutrophil Function: A Novel Strategy to Fight Sepsis.
    Fang H; Jiang W; Cheng J; Lu Y; Liu A; Kan L; Dahmen U
    J Immunol Res; 2015; 2015():187048. PubMed ID: 26798659
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early-phase Innate Immune Suppression in Murine Severe Sepsis Is Restored with Systemic Interferon-β.
    Kusakabe Y; Uchida K; Yamamura Y; Hiruma T; Totsu T; Tamai Y; Tsuyuzaki H; Hasegawa K; Chang K; Yamada Y
    Anesthesiology; 2018 Jul; 129(1):131-142. PubMed ID: 29601323
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction of innate immune memory via microRNA targeting of chromatin remodelling factors.
    Seeley JJ; Baker RG; Mohamed G; Bruns T; Hayden MS; Deshmukh SD; Freedberg DE; Ghosh S
    Nature; 2018 Jul; 559(7712):114-119. PubMed ID: 29950719
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Compartmentalization of the inflammatory response in sepsis and SIRS.
    Cavaillon JM; Annane D
    J Endotoxin Res; 2006; 12(3):151-70. PubMed ID: 16719987
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.